
Ajanta Pharma Ltd
NSE:AJANTPHARM

Intrinsic Value
The intrinsic value of one
AJANTPHARM
stock under the Base Case scenario is
1 914.75
INR.
Compared to the current market price of 2 623 INR,
Ajanta Pharma Ltd
is
Overvalued by 27%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Ajanta Pharma Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Ajanta Pharma Ltd
Balance Sheet Decomposition
Ajanta Pharma Ltd
Current Assets | 27.9B |
Cash & Short-Term Investments | 7.6B |
Receivables | 10.4B |
Other Current Assets | 9.9B |
Non-Current Assets | 20B |
Long-Term Investments | 340m |
PP&E | 17.9B |
Intangibles | 133.2m |
Other Non-Current Assets | 1.7B |
Free Cash Flow Analysis
Ajanta Pharma Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Ajanta Pharma Ltd
Revenue
|
45.3B
INR
|
Cost of Revenue
|
-10.5B
INR
|
Gross Profit
|
34.8B
INR
|
Operating Expenses
|
-23.5B
INR
|
Operating Income
|
11.3B
INR
|
Other Expenses
|
-2.3B
INR
|
Net Income
|
9B
INR
|
AJANTPHARM Profitability Score
Profitability Due Diligence
Ajanta Pharma Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Score
Ajanta Pharma Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
AJANTPHARM Solvency Score
Solvency Due Diligence
Ajanta Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Score
Ajanta Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AJANTPHARM Price Targets Summary
Ajanta Pharma Ltd
According to Wall Street analysts, the average 1-year price target for
AJANTPHARM
is 2 961.57 INR
with a low forecast of 2 000.81 INR and a high forecast of 3 739.05 INR.
Dividends
Current shareholder yield for AJANTPHARM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AJANTPHARM
stock under the Base Case scenario is
1 914.75
INR.
Compared to the current market price of 2 623 INR,
Ajanta Pharma Ltd
is
Overvalued by 27%.